Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

The study titled “Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses” investigates the neurological complications associated with COVID-19. The key findings of the study are: In summary, this comprehensive study provides valuable insights into the neurological impact of COVID-19, emphasizing the role of inflammatory mediators and autoantibodies in these complications, and suggests new avenues for therapeutic intervention. Read More: https://www.nature.com/articles/s41467-023-42320-4

6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records

The study titled “6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records” provides important insights into the neurological and psychiatric effects of COVID-19. Here’s a summary: Background: Despite reports of neurological and psychiatric sequelae from COVID-19, comprehensive data on these effects were lacking. This study aimed to provide detailed incidence rates and risks of neurological and psychiatric diagnoses among COVID-19 patients within six months of diagnosis​​. Methodology: Utilizing the TriNetX Analytics Network, which includes electronic health records from 62 U.S. healthcare organizations, researchers studied a primary cohort of 236,379 patients diagnosed…